The GI Genius processes images in real time with 99.7 percent sensitivity, allowing early detection of lesions. The FDA granted de novo clearance for the device in April.
The system offers a 30 percent increase in lesion detection compared to colonoscopies alone, according to West Orlando News.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.